UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 324

Sortiert nach

Current Diagnosis and Management of Small-Cell Lung Cancer

Mayo Clinic proceedings, 2019-08, Vol.94 (8), p.1599-1622

2019

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future Approaches

Journal of thoracic oncology, 2020-08, Vol.15 (8), p.1281-1297

2020

Link zum Volltext

Verfügbarkeit prüfen

Anti–PD-1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis

Journal of thoracic oncology, 2016-12, Vol.11 (12), p.2048-2050

2016

Link zum Volltext

Verfügbarkeit prüfen

BRAF Alterations as Therapeutic Targets in Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2015-10, Vol.10 (10), p.1396-1403

2015

Link zum Volltext

Verfügbarkeit prüfen

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

Mayo Clinic proceedings, 2008-05, Vol.83 (5), p.584-594

2008

Link zum Volltext

Verfügbarkeit prüfen

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

Journal of thoracic oncology, 2020-06, Vol.15 (6), p.914-947

2020

Link zum Volltext

Verfügbarkeit prüfen

Small Cell Lung Cancer

Mayo Clinic proceedings, 2008-03, Vol.83 (3), p.355-367

2008

Link zum Volltext

Verfügbarkeit prüfen

Intracellular Signal Transduction Pathway Proteins As Targets for Cancer Therapy

Journal of clinical oncology, 2005-08, Vol.23 (23), p.5386-5403

2005

Link zum Volltext

Verfügbarkeit prüfen

The clinical development of MEK inhibitors

Nature reviews. Clinical oncology, 2014-07, Vol.11 (7), p.385-400

2014

Link zum Volltext

Verfügbarkeit prüfen

MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations

Science translational medicine, 2016-02, Vol.8 (324), p.324ra14

2016

Link zum Volltext

Verfügbarkeit prüfen

The Journal of Thoracic Oncology in the Next Decade

Journal of thoracic oncology, 2016-01, Vol.11 (1), p.8-8

Adjei, Alex A.

2016

Link zum Volltext

Verfügbarkeit prüfen

Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing

Carcinogenesis (New York), 2012-07, Vol.33 (7), p.1270-1276

2012

Link zum Volltext

Verfügbarkeit prüfen

Lung Cancer Worldwide

Journal of thoracic oncology, 2019-06, Vol.14 (6), p.956-956

Adjei, Alex A.

2019

Link zum Volltext

Verfügbarkeit prüfen

MET: a promising anticancer therapeutic target

Nature reviews. Clinical oncology, 2012-06, Vol.9 (6), p.314-326

2012

Link zum Volltext

Verfügbarkeit prüfen

The Coming of a New Age: The Journal of Thoracic Oncology Goes Electronic in 2024

Journal of thoracic oncology, 2023-10, Vol.18 (10), p.1257-1257

Adjei, Alex A.

2023

Link zum Volltext

Verfügbarkeit prüfen

Advances in Chemotherapy of Non-small Cell Lung Cancer

Chest, 2006-10, Vol.130 (4), p.1211-1219

2006

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

Journal of clinical oncology, 2004-11, Vol.22 (22), p.4456-4462

2004

Link zum Volltext

Verfügbarkeit prüfen

The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006

Oncogene, 2005-10, Vol.24 (46), p.6861-6869

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426

Journal of clinical oncology, 2010-02, Vol.28 (4), p.614-619

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Journal of clinical oncology, 2005-08, Vol.23 (23), p.5281-5293

2005

Link zum Volltext

Verfügbarkeit prüfen

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

CA: a cancer journal for clinicians, 2013-07, Vol.63 (4), p.249-279

2013

Link zum Volltext

Verfügbarkeit prüfen

Tackling the High Cost of Oncology Drugs

Journal of thoracic oncology, 2021-11, Vol.16 (11), p.1774-1777

Adjei, Alex A.

2021

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer and metastasis: new opportunities and challenges

Cancer and metastasis reviews, 2015-06, Vol.34 (2), p.169-171

2015

Link zum Volltext

Verfügbarkeit prüfen

All That Glitters Is Not Gold: The Story of Rovalpituzumab Tesirine in SCLC

Journal of thoracic oncology, 2021-09, Vol.16 (9), p.1429-1433

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 324

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(320)
Mit Volltextzugriff
(315)

Publikationsform

Artikel
(323)
Tagungsberichte
(1)

Sprache

Englisch
(324)
Japanisch
(43)

Erscheinungsjahr

n.n

Thema

Science & Technology
(192)
Life Sciences & Biomedicine
(191)
Humans
(187)
Oncology
(171)
Female
(81)
Male
(79)
Aged
(72)
Respiratory System
(71)
Middle Aged
(70)
Biological And Medical Sciences
(63)
Medical Sciences
(62)
Lung Neoplasms - Drug Therapy
(54)
Adult
(51)
Tumors
(51)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(41)
Aged, 80 And Over
(40)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(40)
Neoplasms - Drug Therapy
(37)
Treatment Outcome
(35)
Lung Neoplasms - Pathology
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Current Diagnosis and Management of Small-Cell Lung Cancer

Neoadjuvant Immunotherapy for NSCLC: Current Concepts and Future Approaches

Anti–PD-1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis

BRAF Alterations as Therapeutic Targets in Non–Small-Cell Lung Cancer

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

Small Cell Lung Cancer

Intracellular Signal Transduction Pathway Proteins As Targets for Cancer Therapy

The clinical development of MEK inhibitors

MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations

The Use of Radiation Therapy for the Treatment of Malignant Pleural Mesothelioma: Expert Opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

The Journal of Thoracic Oncology in the Next Decade

Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing

Lung Cancer Worldwide

MET: a promising anticancer therapeutic target

The Coming of a New Age: The Journal of Thoracic Oncology Goes Electronic in 2024

Advances in Chemotherapy of Non-small Cell Lung Cancer

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006

Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Tackling the High Cost of Oncology Drugs

Lung cancer and metastasis: new opportunities and challenges

All That Glitters Is Not Gold: The Story of Rovalpituzumab Tesirine in SCLC

Aktive Filter

Suchergebnisse filtern